Recently, a number of large surveys have reported that cancer survivors experience myriad physical, emotional, and practical changes following the completion of their cancer treatment (Brug et al., 2015; Cancer Control Queensland, 2015; Lerro et al, 2012; Li et al., 2019; Moslassiotis et al., 2017; National Health Services, 2015). Such changes can have a profound impact on the daily lives of the survivors. Across these surveys, the types of changes survivors report as remarkably similar include physical limitations, mood swings, fear of recurrence, return to work challenges, and financial burdens. It is important for oncology nurses to know about the nature of the impact of these changes on the lives of cancer survivors, as a basis for their assessment and efforts to improve the experience of survivors.
The recent Canadian Transitions Study (Fitch et al., 2019) provided an opportunity to explore the needs of cancer survivors and gain a deeper understanding of the impact changes could have one to three years following the completion of treatment. One such change described by the responding survivors was cognitive change. This brief communication will present the perspectives of the survivors about living with this consequence of cancer treatment, as reported in the Transition Study and the implications for oncology nursing practice.
METHODS
The full description of the Transition Study methods is presented elsewhere (Fitch et al., 2019). In brief, a survey was distributed to a randomly selected sample of 40,790 cancer survivors from across 10 Canadian provinces. The sample included adult survivors (aged 30+) of breast, prostate, colorectal and melanoma diseases with no metastatic spread, and selected hematological cancers; and adolescents and young adults (AYA, 18 to 29 years) with all non-metastatic cancer types except testes, where metastatic disease was included. Ethical approval was given by the respective ethical boards of the 10 provincial cancer agencies that disseminated the survey.
Several survey questions asked respondents to indicate changes they experienced following completion of their treatment and write comments about these changes. For the purposes of this brief communication, only the responses and comments concerning cognitive changes are presented. Frequency counts were calculated for the numerical data and content analysis was conducted for the written open-ended comments (Hsiu-Fang & Shannon, 2005).
RESULTS
The 13,258 respondents who completed the survey were predominantly adults aged 30+ years of age (97%) and 65% were 65 years of age or older. Fiftyone percent of the respondents were female and 77% had not experienced metastatic disease.
Thirty-nine percent of the respondents indicated they had a concern about changes in concentration or memory. Of those, 21% had a ‘big’ concern and 22% had a ‘moderate’ concern. Only 27% of those with a concern sought help for their concern and of those, 48% experienced difficulty in finding help or did not receive it.
Table 1.
Survey respondents experiencing cognitive changes
| Indication | Number of respondents |
|---|---|
| Number of respondents who answered the question | 11,877 |
| Number of respondents who indicated a concern (big, moderate, small) about changes in concentration or memory | 4,593 |
| Number of respondents who indicated a ‘big’ concern | 970 |
| Number of respondents who indicated a ‘moderate’ concern | 1,627 |
| Number of respondents who sought help for their concern | 1,188 |
| Number of respondents who found it hard/very hard to find help or did not find help for their concern | 564 |
Analysis of the written comments (see Table 2 for illustrative quotes) revealed survivors had many ways of talking about cognitive changes they had experienced, but most frequently used the terms ‘chemo brain’ or ‘chemo fog’. The most frequent description of what they experienced included memory loss (particularly short-term) and inability to concentrate or focus.
Table 2.
Illustrative Quotes: Cognitive changes were a major concern for some survivors
Words used to described cognitive changes
|
How were the changes experienced
|
Expected or not/told or not
|
What is it
|
What causes it
|
Intensity varied
|
Length of time lasting
|
Impact throughout life
|
Impact on thoughts/mood/personality/emotions
|
Impact on confidence
|
Impact on fears
|
Impact on driving
|
Impact on thinking clearly/problem-solving
|
Communication
|
Work
|
Impact on school
|
Strategies – Getting help
|
Strategies – Used on own
|
Need for teaching
|
|
Resources for patients/families Canadian Cancer Society. Coping with Cognitive Problems. http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/managing-side-effects/cognitive-problems British Columbia Cancer Agency. Memory, Thinking and Attention. http://www.bccancer.bc.ca/health-info/coping-with-cancer/managing-symptoms-side-effects/memory-thinking-attention-problems American Cancer Society. Changes in Mood or thinking. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/changes-in-mood-or-thinking.html |
Some of the survivors had been warned about the possibility of cognitive change while others had not. Those who had not been alerted to the possibility of cognitive change happening experienced worry and uncertainty about what was happening. Some indicated they worried they were experiencing dementia or Alzheimer’s.
Most survivors attributed the cognitive changes to their treatment (i.e., surgery, radiation, chemotherapy). In particular, Tamoxifen was named frequently. However, others also added that the shock of the diagnosis, so much happening at once, their age, and menopause could be contributing factors.
Descriptions of the experience revealed variation in the degree of change from “slight memory loss” to “memory was terrible”. For some, the changes were most pronounced immediately following the completion of treatment and gradually improved over the ensuing six months to a year. For others, the improvement took a longer period of time and may not have entirely returned to a pre-treatment level. In the words of one survivor, “Even today I feel I sometimes feel like my memory recovery is still on-going.”(Q33 NB 1010)
Survivors indicated how the cognitive changes had an impact on their ability to think, solve problems, remember even everyday details, and learn new information. Daily activities seemed to take long and confidence was undermined. Not being able to concentrate or recall details influenced their emotions and moods. Some found their communication suffered—not being able to find the right words, thinking one thing and saying something else, or forgetting to tell others about things. Some were not able to drive, as they were not able to handle the traffic or got lost in their neighbourhood. For some, they felt they had to adjust their whole way of living:
Getting back to a new normal. Things have changed regarding my memory and attention span, so I’ve had to adapt my life to these changes. (Q33 Man 1703)
The most significant impacts were felt by individuals who wanted to return to work. Some found they were not able to return while many experienced significant difficulty in doing so, especially as they first returned to the workplace. In the words of one survivor, “The return to work was extremely difficult. I had huge fatigue and concentration was very difficult.”(Q33 NB 655). Others shared the following:
Memory issues and being very tired were the main challenges. I went back to work 8 1/2 months after the surgery, (three months after my last treatment), slowly building back up to full-time. But I found that I was not capable of working full-time. I went down to four days a week and I find that is a more manageable work schedule for me. I still have issues with my memory and being tired. (Q33 BC 2284)
My memory and concentration still suffers. I have tried a return to work for 8 months and could not bear it, and I’m off on disability again. All aspects of my life have drastically changed. (Q37 Man 563)
Survivors used various words to describe the distress they experienced as a result of the cognitive changes – frustration and worry being the words used most frequently. The frustration emerged from not being able to do what they used to do while worry emerged from concerns about whether the changes were permanent or when they would improve. Not knowing where to turn for help or not obtaining assistance heightened both emotions.
IMPLICATIONS FOR ONCOLOGY NURSING PRACTICE
The Transitions Study provided an excellent opportunity to gain insight into what a large sample of survivors were confronting following the completion of their cancer treatment. With almost 40% of the survivors in this study reporting concerns about cognitive changes, this side effect is clearly one that should not be overlooked. Oncology nurses are in an excellent position to support patients and survivors with regards to this distressing side effect.
Based on the perspectives shared by the respondents, early teaching about side effects and preparation for the transition after treatment ought to alert the patient about the potential to experience cognitive changes. Baseline assessment and ongoing surveillance of cognitive status should be a routine part of nursing care so that any alterations are identified early. There are many standardized assessment tools that are easy to administer and score, such as the Montreal Cognitive Assessment Tool (http://www.memorylosstest.com/dl/moca-test-english-7-1.pdf). Self-assessment tools could be shared with the individual for use at home over the ensuing months following the completion of treatment if desired (https://eatspeakthink.com/online-assessment-cognition/). However, simply asking individuals whether they are noticing changes in their memory or concentration can be helpful, as a preliminary screen. Suggesting individuals keep a diary about what is happening may also be a helpful approach. The diary can be used as a reference in future conversations with individuals.
When an individual does experience cognitive change, basic instruction about strategies to handle the situation ought to be shared (see inset for resources for patients), as well as an indication of available resources for further support. Helping the person understand what is happening is important, as well as sharing the message that they do not have to feel alone or isolated in the experience. If the survivor is concerned about their situation, appropriate referral ought to be made for further assessment and/or counselling.
REFERENCES
- Burg MA, Adorno G, Lopez ED, et al. Current unmet needs of cancer survivors: Analysis of open-ended responses to the American Cancer Society study of Cancer survivors II. Cancer. 2015;121:623–630. doi: 10.1002/cncr.28951. [DOI] [PubMed] [Google Scholar]
- Cancer Control Queensland. Survivor Study Results. 2016. http://cancerqld.org.au/research/viertel.cancer:research:centre/community:engagement/survivor:study/
- Fitch MI, Zomer S, Lockwood G, Louzado C, Shaw-Moxam R, Green E. Experiences of adult cancer survivors in transition. Journal of Supportive Care in Cancer. 2019;27:2977–2986. doi: 10.1007/s00520-018-4605-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsiu-Fang H, Shannon S. Three approaches to qualitative content analysis. Qualitative Health Research. 2005;15(9):1277–1288. doi: 10.1177/1049732305276687. [DOI] [PubMed] [Google Scholar]
- Lerro CC, Stein KD, Smith T, Virgo KS. A systematic review of large scale surveys of cancer survivors conducted in North America, 2000–2011. J Cancer Survivorship. 2012;6:115–145. doi: 10.1007/s11764-012-0214-1. [DOI] [PubMed] [Google Scholar]
- Li Q, Lin Y, Zhou H, Xu Y, Xu Y. Supportive care needs and associated factors among Chinese survivors: A cross-sectional study. Support Care Cancer. 2019;27(1):287–295. doi: 10.1007/s00520-018-4315-x. [DOI] [PubMed] [Google Scholar]
- Molassiotis A, Yates P, Li Q, So WKW, Pongthavornkamol K, Pittayapan P, Komatsu H, Thandar M, Yi M, Titus Chacko S, et al. Mapping unmet supportive care needs, quality of life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: Results from the international STEP study. Ann Oncol. 2017;28(10):2552–2558. doi: 10.1093/annonc/mdx350. [DOI] [PubMed] [Google Scholar]
- National Health Service. National Cancer Patient Experience Survey: 2015. 2015. http://www.ncpes.co.uk/Index.php/reports.
